Elevai Labs, Net Worth

Elevai Labs, Net Worth Breakdown

  ELAB
The net worth of Elevai Labs, Common is the difference between its total assets and liabilities. Elevai Labs,'s net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Elevai Labs,'s assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Elevai Labs,'s net worth can be used as a measure of its financial health and stability which can help investors to decide if Elevai Labs, is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Elevai Labs, Common stock.

Elevai Labs, Net Worth Analysis

Elevai Labs,'s net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Elevai Labs,'s financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Elevai Labs,'s overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Elevai Labs,'s net worth analysis. One common approach is to calculate Elevai Labs,'s market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Elevai Labs,'s stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Elevai Labs,'s net worth. This approach calculates the present value of Elevai Labs,'s future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Elevai Labs,'s cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Elevai Labs,'s net worth. This involves comparing Elevai Labs,'s financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Elevai Labs,'s net worth relative to its peers.
To determine if Elevai Labs, is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Elevai Labs,'s net worth research are outlined below:
Elevai Labs, Common generated a negative expected return over the last 90 days
Elevai Labs, Common has high historical volatility and very poor performance
The company reported the previous year's revenue of 1.71 M. Net Loss for the year was (4.3 M) with profit before overhead, payroll, taxes, and interest of 1.74 M.
Elevai Labs, generates negative cash flow from operations
Latest headline from simplywall.st: Is PMGC Holdings In A Good Position To Invest In Growth
Elevai Labs, uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Elevai Labs, Common. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Elevai Labs,'s previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
11th of March 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

Follow Elevai Labs,'s market capitalization trends

The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.25 M.

Market Cap

0.0

Project Elevai Labs,'s profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(0.75)(0.78)
Return On Capital Employed(1.08)(1.03)
Return On Assets(0.75)(0.78)
Return On Equity(1.29)(1.23)
The company has Profit Margin (PM) of (2.24) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.67) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.67.
When accessing Elevai Labs,'s net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Elevai Labs,'s profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Elevai Labs,'s profitability and make more informed investment decisions.
Please note, the presentation of Elevai Labs,'s financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Elevai Labs,'s management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Elevai Labs,'s management manipulating its earnings.

Evaluate Elevai Labs,'s management efficiency

Elevai Labs, Common has return on total asset (ROA) of (0.4826) % which means that it has lost $0.4826 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.3035) %, meaning that it created substantial loss on money invested by shareholders. Elevai Labs,'s management efficiency ratios could be used to measure how well Elevai Labs, manages its routine affairs as well as how well it operates its assets and liabilities. As of March 20, 2025, Return On Tangible Assets is expected to decline to -0.78. The current year's Return On Capital Employed is expected to grow to -1.03. At present, Elevai Labs,'s Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 1.3 M, whereas Non Current Assets Total are forecasted to decline to about 253.4 K.
Last ReportedProjected for Next Year
Book Value Per Share 0.32  0.34 
Tangible Book Value Per Share 0.32  0.34 
Enterprise Value Over EBITDA(828.25)(869.66)
Price Book Value Ratio 924.91  971.16 
Enterprise Value Multiple(828.25)(869.66)
Price Fair Value 924.91  971.16 
Evaluating the management effectiveness of Elevai Labs, allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The Elevai Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Enterprise Value Revenue
2.5884
Revenue
2.4 M
Quarterly Revenue Growth
(0.05)
Revenue Per Share
194.032
Return On Equity
(1.30)
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Elevai Labs, insiders, such as employees or executives, is commonly permitted as long as it does not rely on Elevai Labs,'s material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Elevai Labs, insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Elevai Labs, time-series forecasting models is one of many Elevai Labs,'s stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Elevai Labs,'s historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Elevai Labs, Earnings per Share Projection vs Actual

Elevai Labs, Corporate Executives

Elected by the shareholders, the Elevai Labs,'s board of directors comprises two types of representatives: Elevai Labs, inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Elevai. The board's role is to monitor Elevai Labs,'s management team and ensure that shareholders' interests are well served. Elevai Labs,'s inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Elevai Labs,'s outside directors are responsible for providing unbiased perspectives on the board's policies.
FACS FACSChief CoFounderProfile
Graydon CFASecretary CFOProfile
When determining whether Elevai Labs, Common offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Elevai Labs,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Elevai Labs, Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Elevai Labs, Common Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elevai Labs, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Elevai Labs,. If investors know Elevai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Elevai Labs, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(622.43)
Revenue Per Share
194.032
Quarterly Revenue Growth
(0.05)
Return On Assets
(0.48)
Return On Equity
(1.30)
The market value of Elevai Labs, Common is measured differently than its book value, which is the value of Elevai that is recorded on the company's balance sheet. Investors also form their own opinion of Elevai Labs,'s value that differs from its market value or its book value, called intrinsic value, which is Elevai Labs,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Elevai Labs,'s market value can be influenced by many factors that don't directly affect Elevai Labs,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Elevai Labs,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Elevai Labs, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Elevai Labs,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.